Syngene International Ltd
Platinum
Information
Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated contract research, development and manufacturing organisation providing scientific services -- from early discovery to commercial supply. Our innovative capabilities for novel molecular entities (NMEs) cater to pharma, biotech, nutrition, animal health, consumer goods and speciality chemical companies
Products
Small & large molecule Discovery & Development
Integrated Drug Substance-Drug Product development
Clinical supplies
Antibody Drug Conjugates
Oligonucleotide Synthesis
Acute, sub-chronic and chronic toxicity studies
ADME/DMPK
Analytical characterization & quality control
analytical method development
Analytical method development and validation